About Sabra Health Care REIT, Inc.
https://www.sabrahealth.comAs of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment.
CEO
Richard K. Matros
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2010-11-16 | Reverse | 1:3 |
ETFs Holding This Stock
Summary
Showing Top 3 of 247
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
JMP Securities
Market Outperform
Citizens Capital Markets
Market Outperform
Wells Fargo
Overweight
BMO Capital
Market Perform
Scotiabank
Sector Perform
Truist Securities
Hold
Grade Summary
Showing Top 6 of 6
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:37.1M
Value:$714.96M
VANGUARD GROUP INC
Shares:34.95M
Value:$673.46M
BLACKROCK INC.
Shares:34.39M
Value:$662.64M
Summary
Showing Top 3 of 544
About Sabra Health Care REIT, Inc.
https://www.sabrahealth.comAs of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $190.04M ▲ | $60.83M ▲ | $22.54M ▼ | 11.86% ▼ | $0.09 ▼ | $100.36M ▼ |
| Q2-2025 | $189.15M ▲ | $56.1M ▼ | $65.54M ▲ | 34.65% ▲ | $0.28 ▲ | $137.17M ▲ |
| Q1-2025 | $183.54M ▲ | $56.22M ▲ | $40.3M ▼ | 21.96% ▼ | $0.17 ▼ | $111.31M ▼ |
| Q4-2024 | $182.35M ▲ | $55.22M ▲ | $46.7M ▲ | 25.61% ▲ | $0.2 ▲ | $125.19M ▲ |
| Q3-2024 | $178M | $55.12M | $29.79M | 16.73% | $0.13 | $101.71M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $200.6M ▲ | $5.56B ▲ | $2.74B ▲ | $2.82B ▲ |
| Q2-2025 | $95.17M ▲ | $5.33B ▲ | $2.62B ▲ | $2.71B ▲ |
| Q1-2025 | $22.65M ▼ | $5.23B ▼ | $2.53B ▼ | $2.7B ▼ |
| Q4-2024 | $60.47M ▼ | $5.3B ▼ | $2.56B ▼ | $2.74B ▼ |
| Q3-2024 | $63M | $5.37B | $2.62B | $2.74B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $22.52M ▼ | $99.96M ▲ | $-199.84M ▼ | $206.17M ▲ | $105.87M ▲ | $99.96M ▲ |
| Q2-2025 | $65.54M ▲ | $80.96M ▲ | $-45.13M ▼ | $36.73M ▲ | $72.75M ▲ | $80.96M ▲ |
| Q1-2025 | $40.3M ▼ | $80.26M ▲ | $-16.44M ▼ | $-101.24M ▼ | $-37.44M ▼ | $80.26M ▲ |
| Q4-2024 | $46.7M ▲ | $79.97M ▼ | $18.56M ▲ | $-100.96M ▼ | $-2.64M ▼ | $79.97M ▼ |
| Q3-2024 | $29.79M | $97.65M | $-57.03M | $-13.96M | $26.67M | $97.65M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Health Care Resident Service Ancillary Service | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Richard K. Matros
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2010-11-16 | Reverse | 1:3 |
ETFs Holding This Stock
Summary
Showing Top 3 of 247
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
JMP Securities
Market Outperform
Citizens Capital Markets
Market Outperform
Wells Fargo
Overweight
BMO Capital
Market Perform
Scotiabank
Sector Perform
Truist Securities
Hold
Grade Summary
Showing Top 6 of 6
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:37.1M
Value:$714.96M
VANGUARD GROUP INC
Shares:34.95M
Value:$673.46M
BLACKROCK INC.
Shares:34.39M
Value:$662.64M
Summary
Showing Top 3 of 544